Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1997-6-12
|
pubmed:abstractText |
Prostate specific antigen, specific organ and tissue marker, is a glycoprotein present in serum in different molecular forms, i.e. not protein bound and bound to proteins (PSA-ACT and PSA-AMG). The total PSA is expressed by the sum of the non protein bound value (free-PSA) and PSA-ACT. The aim of our study was to evaluate the hypothesis that measurement of free/total PSA ratio may be helpful in the differential diagnosis of prostatic pathology. Our study was conducted on 350 patients, to whom the total-PSA, free-PSA and f/t PSA had been performed; 250 patients showed a total PSA between 2.5 and 10 ng/ml and 185 of them had symptoms of bladder out-flow obstruction. In all of the 250 patients digital rectal examination, transrectal ultrasound and prostatic biopsy were performed. 100 patients were controls. The cut-off to differentiate between benign and malignant prostatic disease was 16%. The pathologic diagnosis was related to the f/t PSA ratio, and in particular those patients with a f/t PSA lower than 16% were expected to be prostatic carcinoma, while those with a f/t PSA higher than 16% were expected to be benign prostatic hypertrophy. The diagnostic accuracy of the ratio was calculated, and it was observed that it was 88.65% in the diagnosis of benign prostatic hypertrophy, while in the diagnosis of prostatic carcinoma it was 84.5%. We can therefore assume that f/t PSA can add useful information on prostatic pathology, eventually sparing unnecessary prostatic biopsies.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1124-3562
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
69 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
93-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9181932-Adult,
pubmed-meshheading:9181932-Aged,
pubmed-meshheading:9181932-Aged, 80 and over,
pubmed-meshheading:9181932-Humans,
pubmed-meshheading:9181932-Male,
pubmed-meshheading:9181932-Middle Aged,
pubmed-meshheading:9181932-Prostate-Specific Antigen,
pubmed-meshheading:9181932-Prostatic Neoplasms,
pubmed-meshheading:9181932-Reproducibility of Results,
pubmed-meshheading:9181932-Sensitivity and Specificity
|
pubmed:year |
1997
|
pubmed:articleTitle |
[Diagnostic efficacy of free SPA/total PSA ratio in the diagnosis of prostatic carcinoma].
|
pubmed:affiliation |
Clinica Urologica, Università degli Studi, Ancona.
|
pubmed:publicationType |
Journal Article,
English Abstract
|